UCB SA Valuation
| UCB Stock | EUR 181.55 1.30 0.72% |
At this time, the entity appears to be fairly valued. UCB SA owns a latest Real Value of €177.46 per share. The recent price of the entity is €181.55. Our model measures the value of UCB SA from evaluating the entity fundamentals such as Profit Margin of 0.15 %, return on asset of 0.0468, and Shares Owned By Insiders of 38.03 % as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that UCB SA's price fluctuation is very steady at this time. Calculation of the real value of UCB SA is based on 3 months time horizon. Increasing UCB SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the UCB stock is determined by what a typical buyer is willing to pay for full or partial control of UCB SA. Since UCB SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of UCB Stock. However, UCB SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 181.55 | Real 177.46 | Hype 181.55 |
The intrinsic value of UCB SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence UCB SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of UCB SA helps investors to forecast how UCB stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of UCB SA more accurately as focusing exclusively on UCB SA's fundamentals will not take into account other important factors: UCB SA Total Value Analysis
UCB SA is at this time forecasted to have takeover price of 15.81 B with market capitalization of 14.84 B, debt of 1.97 B, and cash on hands of 1.28 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the UCB SA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.81 B | 14.84 B | 1.97 B | 1.28 B |
UCB SA Investor Information
About 38.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.55. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. UCB SA last dividend was issued on the 29th of April 2022. The entity had 100:1 split on the 4th of January 1999. Based on the key measurements obtained from UCB SA's financial statements, UCB SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.UCB SA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. UCB SA has an asset utilization ratio of 40.65 percent. This connotes that the Company is making €0.41 for each dollar of assets. An increasing asset utilization means that UCB SA is more efficient with each dollar of assets it utilizes for everyday operations.UCB SA Ownership Allocation
UCB SA secures a total of 189.96 Million outstanding shares. UCB SA shows substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.UCB SA Profitability Analysis
The company reported the revenue of 5.78 B. Net Income was 1.06 B with profit before overhead, payroll, taxes, and interest of 4.34 B.About UCB SA Valuation
The stock valuation mechanism determines UCB SA's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of UCB SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of UCB SA. We calculate exposure to UCB SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of UCB SA's related companies.UCB SA, a biopharmaceutical company, researches, develops, manufactures, sells, and distributes biopharmaceutical solutions for people living with neurology and immunology conditions. The company was founded in 1928 and is headquartered in Brussels, Belgium. UCB SA operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 6828 people.
8 Steps to conduct UCB SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates UCB SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct UCB SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain UCB SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine UCB SA's revenue streams: Identify UCB SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research UCB SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish UCB SA's growth potential: Evaluate UCB SA's management, business model, and growth potential.
- Determine UCB SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate UCB SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for UCB Stock Analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.